Delivery Order SPE2DR25D3301-SPE2DR26F18DB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,304.98 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials on November 14, 2025, with completion scheduled for November 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,360.20 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This non-set-aside contract, awarded on August 21, 2025, with a completion date of August 22, 2025, represents a firm fixed-price delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $13,321.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for Injectafer 750 mg/15 ml vials on October 31, 2025, with completion targeted for November 3, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a $19,061.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Injectafer 750 mg/15 mL vials. This non-set-aside contract, with a completion date of August 26, 2025, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical prime vendor vehicle with DLA, reflecting the agency's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for the supply of Injectafer 750 mg/15 ml vials. This is a firm fixed price delivery order with a ceiling value of $27,463.25 and an ultimate completion date of September 2, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and was awarded without a set-aside designation, indicating competitive procurement. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $12,628.53 firm fixed-price delivery order by the Defense Logistics Agency on August 29, 2025, for the supply of Injectafer 750 mg/15 mL vials. This non-set-aside, competitively awarded contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 19, 2025, for the supply of Injectafer 750 mg/15 ml vials. The contract has a ceiling value of $10,756.00 and is structured as a firm fixed price delivery order with an ultimate completion date of September 22, 2025. This award was not issued under any set-aside program and was competitively awarded. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $12,066.50 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This competitive award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $5,499.85 to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,520,349 units of the pharmaceutical product Injectafer, a 750 mg/15 mL vial. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, under which AmerisourceBergen provides a comprehensive range of medical commodities to...
- The Defense Logistics Agency awarded a delivery order valued at $12,893.58 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials on May 6, 2025, with completion scheduled for May 7, 2025. This non-set-aside, firm fixed-price contract represents a routine pharmaceutical procurement under AmerisourceBergen's broader federal supply agreement. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F18DBDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $13,203.17 from the Defense Logistics Agency (DLA) on November 17, 2025, for the supply of Injectafer 750 mg/15 ml vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 18, 2025, indicating a rapid fulfillment requirement. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Injectafer, an iron replacement therapy, represents the type of specialty pharmaceutical commodities that fall within the scope of this prime vendor contract. Through this strategic vehicle, AmerisourceBergen supports critical healthcare needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The competitive award of this delivery order reflects the company's established capability to meet federal medical procurement requirements and its significant role within the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.2k | 11/17/25 |